SS

Satya Sandipan Panigrahy

Active Director Director DIN 10571202
DIN 10571202 First appointment Mar 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Satya Sandipan Panigrahy

Data last updated:

Satya Sandipan Panigrahy is a Director at Linox Ortho Surgical Private Limited (since 2024). The company operates in Healthcare.

DIN 10571202
Primary Designation Director
Industry Healthcare
First Appointment 30 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Linox Ortho Surgical Private Limited U32506OD2024PTC045417
Director30 Mar 20242024Active

Board colleagues of Satya Sandipan Panigrahy

NameDINCompanyDesignation
Rabi Narayan Acharya10571201Linox Ortho Surgical Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Linox Ortho Surgical Private Limited
Premium access

Shareholding and investment profile for Satya Sandipan Panigrahy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Satya Sandipan Panigrahy

Satya Sandipan Panigrahy currently holds 1 directorship: Linox Ortho Surgical Private Limited (Director, since 30 Mar 2024).

Satya Sandipan Panigrahy was first appointed on 30 Mar 2024 as Director at Linox Ortho Surgical Private Limited.

The current boards of Satya Sandipan Panigrahy's companies include Rabi Narayan Acharya (Linox Ortho Surgical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available